Login / Signup

Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis.

Jiamin LuYuqian FengKaibo GuoLeitao SunShanming RuanKai Zhang
Published in: Journal of cancer research and clinical oncology (2024)
The evaluation of the prognostic value of preoperative ctDNA revealed that preoperative ctDNA might be used as a prognostic biomarker for patients with LUAD or those with stage I-II NSCLC. In addition, postoperative AT is recommended for NSCLC patients with positive preoperative ctDNA, regardless of the disease stage and subtype.
Keyphrases
  • circulating tumor
  • patients undergoing
  • cell free
  • circulating tumor cells
  • small cell lung cancer
  • advanced non small cell lung cancer
  • tyrosine kinase
  • brain metastases
  • epidermal growth factor receptor